Orphan Biologics Should Get Two Extra Years Of Exclusivity, NORD Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Organization tells Rep. Waxman it still "wholeheartedly" supports his bill, but is planning its legislative approach around longer brand exclusivity.